|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/095 | |
| A61K 39/102 | |||
| A61K 39/116 |
| (11) | Patento numeris | 2201961 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10158046.2 |
| Europos patento paraiškos padavimo data | 2006-06-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-06-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0513069 | 2005-06-27 | GB | |
| 0513071 | 2005-06-27 | GB | |
| 0515556 | 2005-07-28 | GB | |
| 0524204 | 2005-11-28 | GB | |
| 0526040 | 2005-12-21 | GB | |
| 0526041 | 2005-12-21 | GB |
| (72) |
Biemans, Ralph Leon, BE
Poolman, Jan, BE
Duvivier, Pierre, BE
Denoel, Philippe, BE
Capiau, Carine, BE
Boutriau, Dominique, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | Immunogenic composition |
| Immunogenic composition |